Droperidol on Prevention of Cannabis Hyperemesis Syndrome

Clinical trial NCT05244460 · UNKNOWN

Trial details

NCT number: NCT05244460
Sponsor: Mercy Health Ohio
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Cannabis Hyperemesis Syndrome

Start date: 2021-12-02
Primary completion: 2023-01-31
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.